Cargando…

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction

BACKGROUND: Adenocarcinoma of the esophagogastric junction (AEG) is increasing worldwide. Lymph node metastasis is an important clinical issue in AEG patients. This study investigated the usefulness of a positive lymph node ratio (PLNR) to stratify prognosis and evaluate stage migration. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamiya, Hajime, Komatsu, Shuhei, Nishibeppu, Keiji, Ohashi, Takuma, Konishi, Hirotaka, Shiozaki, Atsushi, Kubota, Takeshi, Fujiwara, Hitoshi, Okamoto, Kazuma, Otsuji, Eigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996992/
https://www.ncbi.nlm.nih.gov/pubmed/36890486
http://dx.doi.org/10.1186/s12885-023-10689-6
_version_ 1784903167336513536
author Kamiya, Hajime
Komatsu, Shuhei
Nishibeppu, Keiji
Ohashi, Takuma
Konishi, Hirotaka
Shiozaki, Atsushi
Kubota, Takeshi
Fujiwara, Hitoshi
Okamoto, Kazuma
Otsuji, Eigo
author_facet Kamiya, Hajime
Komatsu, Shuhei
Nishibeppu, Keiji
Ohashi, Takuma
Konishi, Hirotaka
Shiozaki, Atsushi
Kubota, Takeshi
Fujiwara, Hitoshi
Okamoto, Kazuma
Otsuji, Eigo
author_sort Kamiya, Hajime
collection PubMed
description BACKGROUND: Adenocarcinoma of the esophagogastric junction (AEG) is increasing worldwide. Lymph node metastasis is an important clinical issue in AEG patients. This study investigated the usefulness of a positive lymph node ratio (PLNR) to stratify prognosis and evaluate stage migration. METHODS: We retrospectively analysed 117 consecutive AEG patients (Siewert type I or II) who received a lymphadenectomy between 2000 and 2016. RESULTS: A PLNR cut-off value of 0.1 most effectively stratified patient prognosis into two groups (P < 0.001). Also, prognosis could be clearly stratified into four groups: PLNR = 0, 0 < PLNR < 0.1, 0.1 ≤ PLNR < 0.2, and 0.2 ≤ PLNR (P < 0.001, 5-year survival rates (88.6%, 61.1%, 34.3%, 10.7%)). A PLNR ≥ 0.1 significantly correlated with tumour diameter ≥ 4 cm (P < 0.001), tumour depth (P < 0.001), greater pathological N-status (P < 0.001), greater pathological Stage (P < 0.001), and oesophageal invasion length ≥ 2 cm (P = 0.002). A PLNR ≥ 0.1 was a poor independent prognostic factor (hazard ratio 6.47, P < 0.001). The PLNR could stratify prognosis if at least 11 lymph nodes were retrieved. A 0.2 PLNR cut-off value discriminated a stage migration effect in pN3 and pStage IV (P = 0.041, P = 0.015) patients; PLNR ≥ 0.2 might potentially diagnose a worse prognosis and need meticulous follow-up post-surgery. CONCLUSION: Using PLNR, we can evaluate the prognosis and detect higher malignant cases who need meticulous treatments and follow-up in the same pStage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10689-6.
format Online
Article
Text
id pubmed-9996992
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99969922023-03-10 Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction Kamiya, Hajime Komatsu, Shuhei Nishibeppu, Keiji Ohashi, Takuma Konishi, Hirotaka Shiozaki, Atsushi Kubota, Takeshi Fujiwara, Hitoshi Okamoto, Kazuma Otsuji, Eigo BMC Cancer Research BACKGROUND: Adenocarcinoma of the esophagogastric junction (AEG) is increasing worldwide. Lymph node metastasis is an important clinical issue in AEG patients. This study investigated the usefulness of a positive lymph node ratio (PLNR) to stratify prognosis and evaluate stage migration. METHODS: We retrospectively analysed 117 consecutive AEG patients (Siewert type I or II) who received a lymphadenectomy between 2000 and 2016. RESULTS: A PLNR cut-off value of 0.1 most effectively stratified patient prognosis into two groups (P < 0.001). Also, prognosis could be clearly stratified into four groups: PLNR = 0, 0 < PLNR < 0.1, 0.1 ≤ PLNR < 0.2, and 0.2 ≤ PLNR (P < 0.001, 5-year survival rates (88.6%, 61.1%, 34.3%, 10.7%)). A PLNR ≥ 0.1 significantly correlated with tumour diameter ≥ 4 cm (P < 0.001), tumour depth (P < 0.001), greater pathological N-status (P < 0.001), greater pathological Stage (P < 0.001), and oesophageal invasion length ≥ 2 cm (P = 0.002). A PLNR ≥ 0.1 was a poor independent prognostic factor (hazard ratio 6.47, P < 0.001). The PLNR could stratify prognosis if at least 11 lymph nodes were retrieved. A 0.2 PLNR cut-off value discriminated a stage migration effect in pN3 and pStage IV (P = 0.041, P = 0.015) patients; PLNR ≥ 0.2 might potentially diagnose a worse prognosis and need meticulous follow-up post-surgery. CONCLUSION: Using PLNR, we can evaluate the prognosis and detect higher malignant cases who need meticulous treatments and follow-up in the same pStage. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10689-6. BioMed Central 2023-03-08 /pmc/articles/PMC9996992/ /pubmed/36890486 http://dx.doi.org/10.1186/s12885-023-10689-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kamiya, Hajime
Komatsu, Shuhei
Nishibeppu, Keiji
Ohashi, Takuma
Konishi, Hirotaka
Shiozaki, Atsushi
Kubota, Takeshi
Fujiwara, Hitoshi
Okamoto, Kazuma
Otsuji, Eigo
Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
title Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
title_full Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
title_fullStr Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
title_full_unstemmed Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
title_short Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
title_sort evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996992/
https://www.ncbi.nlm.nih.gov/pubmed/36890486
http://dx.doi.org/10.1186/s12885-023-10689-6
work_keys_str_mv AT kamiyahajime evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT komatsushuhei evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT nishibeppukeiji evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT ohashitakuma evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT konishihirotaka evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT shiozakiatsushi evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT kubotatakeshi evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT fujiwarahitoshi evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT okamotokazuma evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction
AT otsujieigo evaluatingprognosticvalueandstagemigrationeffectsusingapositivelymphnoderatioinadenocarcinomaoftheesophagogastricjunction